Jefferies initiated coverage on Foghorn Therapeutics with a new price target
$FHTX
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies initiated coverage of Foghorn Therapeutics with a rating of Buy and set a new price target of $18.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/23/2025 | $9.00 | Mkt Outperform | Citizens JMP |
| 1/30/2025 | $10.00 | Buy | B. Riley Securities |
| 9/3/2024 | $18.00 | Buy | Jefferies |
| 8/19/2024 | $20.00 | Outperform | Evercore ISI |
| 3/28/2023 | $10.00 | Buy | BofA Securities |
| 1/5/2023 | $20.00 | Outperform | BMO Capital Markets |
| 12/15/2021 | $23.00 → $26.00 | Overweight | Morgan Stanley |
| 11/22/2021 | $25.00 | Buy | HC Wainwright & Co. |